Remote Use of the Asthma Control Test (ACT) to Improve Care of Children With Asthma
1 other identifier
observational
221
1 country
1
Brief Summary
This study will assess whether adaption of the Asthma Control Test (ACT) and childhood Asthma Control Test (cACT) for mobile devices improves rate of completion and improves control of asthma in children and adolescents
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2015
CompletedStudy Start
First participant enrolled
January 1, 2016
CompletedFirst Posted
Study publicly available on registry
January 31, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2017
CompletedMarch 27, 2018
March 1, 2018
1.3 years
July 27, 2015
March 26, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Well-controlled asthma
Percent of ACT scores with value of 20 or greater
Each month for one calendar year
Secondary Outcomes (1)
Asthma Emergency Department visits and hospitalizations
Total Emergency Department Visits and hospitalizations with asthma as one of top diagnosis in one year
Study Arms (1)
Use of Mobile ACT
Will answer ACT (or cACT) and other asthma questions using mobile app
Eligibility Criteria
Patients with asthma seen in one of the clinics caring for patients with asthma at Boston Children's Hospital Age 4-21
You may qualify if:
- Diagnosis of asthma
- Cared for at Boston Children's Hospital (Primary or secondary care)
You may not qualify if:
- Age \<4 or \>21
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Boston Childrens Hospital
Boston, Massachusetts, 02115, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew MacGinnitie, MD PhD
Boston Children's Hosptial
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Clinical Director, Division of Immunology
Study Record Dates
First Submitted
July 27, 2015
First Posted
January 31, 2017
Study Start
January 1, 2016
Primary Completion
April 30, 2017
Study Completion
December 31, 2017
Last Updated
March 27, 2018
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will share
Will make deidentified data available for other researchers